Introduction
Lobular breast cancer is a nuanced and often misunderstood form of breast cancer that accounts for about 10-15% of all cases. If you or someone you know is grappling with lobular breast cancer, you might find yourself struggling to find adequate information. Many cancer patients share frustrations about the lack of resources dedicated specifically to lobular breast cancer, especially regarding its detection, treatment options, and likelihood of recurrence.
If you’re curious about what makes lobular breast cancer distinct and how it is different from ductal breast cancer, you’re not alone. In this article, I will provide in-depth insights into lobular breast cancer, including its diagnosis, treatment protocols, survival rates, and the future of research in this area.
What is Lobular Breast Cancer?
Lobular breast cancer originates from the glandular tissue of the breast, which typically produces milk. Here's a brief overview of its characteristics:
- Prevalence: Represents 10-15% of breast cancer cases
- Common Age Group: More prevalent in menopausal women
- Growth Pattern: Tends to grow in a single-file pattern rather than clusters
- Genetic Characteristics: Over 90% are ER positive and HER2 negative, and they are typically grade two cancers, indicating a slow growth rate.
Distinction from Ductal Breast Cancer
While ductal carcinomas arise from the cells lining the ducts of the breast and are more easily detected through mammograms, lobular cancers' insidious growth makes them harder to diagnose. Their tendency to spread out creates what is often termed as a “sneaky” cancer, making early detection challenging.
Symptoms of Lobular Breast Cancer
Identifying lobular breast cancer can be complex due to its less distinct symptoms compared to ductal type cancers. Unusual signs may include:
- Skin dimpling
- A fuller or thicker breast
- Changes in nipple position (pulling inwards)
Why Regular Self-Checks are Important
Despite the stealthy manner in which lobular cancers grow, conducting regular self-examinations remains crucial. If you notice unusual changes, consult your healthcare provider as it could lead to early diagnosis and better treatment outcomes.
Diagnosis of Lobular Breast Cancer
Lobular breast cancer frequently evades early detection methods, making timely diagnosis critical. Here are the primary diagnostic methods used:
- Mammograms: Detect about 2/3 of lobular cancers.
- Ultrasound: Increases detection rates to 90%, however, still can miss around 10%.
- MRI: Could identify over 95% of lobular cancers, but it may not always capture certain lesions, known as occult cancers.
Given their growth pattern, lobular cancers often require thorough diagnostic imaging to clearly understand the size and progression before dermatological interventions.
Treatment Protocols for Lobular Breast Cancer
The treatment for lobular breast cancer mirrors the general strategies employed for various other breast cancer types, predominantly comprising:
- Surgery: Either lumpectomy or myectomy, depending on individual circumstances.
- Radiotherapy: Very common in post-operative care to reduce recurrence risks.
- Chemotherapy & Hormonal Therapy: Typically used for ER-positive lobular cancers, chemotherapy is less effective due to the slow growth nature, therefore hormonal therapy tends to be the primary focus.
- Targeted Therapy: Patients may also receive newer treatments such as CDK inhibitors alongside hormone blockers.
Why Chemotherapy is Often Less Effective
Many lobular cancers, being slower-growing, do not respond as well to chemotherapy compared to the more aggressive ductal cancers. Medical professionals continuously examine the need for chemotherapy on a case-by-case basis.
Recurrence of Lobular Breast Cancer
Many patients inquire about the likelihood of recurrence. Notably, lobular breast cancer displays different recurrence patterns:
- Initial Years: May present fewer initial recurrences compared to ductal types, but research indicates rising rates of recurrence post ten years.
- Symptoms of Recurrence: Keep an eye out for changes in previous surgery sites, swollen lymph nodes, or other unusual signs that persist for more than a few weeks.
Survival Rates and Prognosis
Survival rates depend on various factors including tumor size, grade, lymph node involvement, and individual health status. It’s essential to note that while early data indicated lobular cancer may have better outcomes in the first five years, there are increasing concerns over long-term recurrence as survivors surpass the ten-year mark.
Future Research Directions
Research into lobular breast cancer is gaining momentum due to its unique characteristics. Innovative areas under exploration include:
- Immunotherapy: Early trials indicate lobular breast cancers may have better immune recognition capabilities.
- Novel Targeted Treatments: Studies examine specific genetic mutations common in lobular patients, aiming to enhance hormonal therapy responses.
- Liquid Biopsies: A prospective advancement that may aid in early detection of metastatic disease in lobular cancer patients.
Importance of Increased Research Funding
Both patients and advocacy groups are calling for greater research focus and funding aimed at understanding lobular breast cancer more comprehensively. As patients become increasingly vocal about their experiences and needs, it is hoped that healthcare professionals and researchers will prioritize these efforts.
Conclusion
In summary, lobular breast cancer is a unique and sometimes elusive type of breast cancer with distinct characteristics and treatment requirements. As more patients share their experiences and support groups grow, the landscape for lobular breast cancer is improving.
Staying informed and connected with dedicated resources is crucial. Embracing research and raising awareness can make a significant difference in the lives of those affected. Whether you are navigating your health journey or supporting others, ensuring you have the latest and most accurate information about lobular breast cancer will empower you and the broader breast cancer community.
have you got lobular breast cancer are you struggling to get information about it do you want to know if it's treated
differently is it more likely to come back in the future and why are there so few trials for it if that's you you're
not alone I had lobular breast cancer and I got frustrated at how little information there is thankfully things
have changed and there are now dedicated support and research groups just for us and I'll put the links in the video
notes today I'm going to tell you everything there is to know about lobular cancer what it is how it's
detected and how it's treated you'll learn the unusual symptoms of lob recurrence that you need to be wary of
and finally I'll share the latest research and what the fature holds before I start I thought I'd tell you a
little bit about my own lobular cancer Journey feel free to skip ahead to the next chapter if you already know this
now I was diagnosed with stage three mixed ductal and lobular cancer back in 2015 when I was 40 it wasn't seen on a
mamogram only on the ultrasound and the MRI I had chemo first and my final MRI showed that my cancer had disappeared
yay except it hadn't only the ductal bit had gone and my myectomy showed there was still 13 cm of lobular cancer left
in my breast and that wasn't seen on the MRI it was ear positive and her two negative 3 years later I had a local
Regional recurrence on my chest wall and 7even months ago I had a second local recurrence above my myectomy scar now I
should warn you that you will hear me say a lot of breast cancer specific words that may be new to you these are
all words that I've explained before in some of my other videos I'll highlight the videos as we go along and I'll list
them all in the notes so you can go and watch them later so what is lobular breast cancer well breast cancers
develop from cells in the breasts and 80% of breast cancers come from the cells align the ducts that carry milk
through the breast to the nipple they're called ductal cancer or cancers of no special type lobular cancers come from
the glandular tissue of the brain breast that's the pink bit that you can see that's the bit of the breast that makes
the milk if you do get pregnant and they make up 10 to 15% of all cancers they're more common in menopausal women and over
90% of lobular cancers are grade two slow growing ER positive and her2 negative and you can find out more about
those terms in this video lobular cancers also tend to be larger than ductal cancers when they're diagnosed
often over 5 cm in size they're also more likely to be multifocal or multicentric a multifocal cancer means
there's more than one cancer in one area of your breast like a cluster of cancers or within 5 cm a multicentric cancer
means there are several cancers in different areas of your breast and this nearly always means you'll need to have
a myectomy to remove them lobular cancers are also more likely to be found in both breasts at the same time called
bilateral breast cancer and this is more common in younger women there's also another rare type of lobular breast
cancer called pleomorphic lobular breast cancer and there's not a lot of information about it they tend to be
grade three faster growing and are much more likely to spread to the lymph nodes but for the rest of this video I'm just
going to talk about normal lobular cancer so why is it so hard to find see lobular cancers are sneaky and they grow
in a single file like a bed sheet instead of forming a clump and that's because they don't have a molecule
called e cateran on their cell surface eerin is like an anchoring protein it makes cells sticky all ductal cancer
cells have it and that's why they grow together in clumps that are easy to see on a mamogram or easy for you to feel
but because the lobular cancers spread out in single file they are much harder to see on a mamogram or for you to
notice a lump eventually the sheets of cells will merge forming a mass but by the time this happens the cancer has
often spread to the lymph nodes so how are they diagnosed well lular cancers be hard to find when you check your breasts
I'm a breast surgeon and I didn't know I had a 13 cm cancer in my breast and I've got expert hands I missed it because the
lobular cancer had formed a web through the hole of my breast instead of a palpable lump I only saw the ductal bit
that had formed a lump lobular cancers are more likely to present with a skin dimpling a thicker fuller breast or your
nipple being pulled in and that's why it's still important that you check your breasts regularly so you can pick up
these signs we do still still use mammograms as the first scan because we don't know what kind of cancer you have
until we do a biopsy now mammograms do pick up almost 2/3 of all lobular cancers however a third of all lobular
cancers are only seen on one View Ultrasound scans will find around 90% of all lular cancers but they still miss
one in 10 of them now magnetic resonance imaging or MRI is normally done in anyone with a lobular cancer that isn't
easily seen on a mamogram m eyes will pick up over 95% of all lobular cancers but they can still miss some which is
what happened to me these are called occult cancers and at the moment there's no other way of screening them MRI scans
are also done because they'll often show that a lobular cancer is bigger than first thought and it's important to know
this because it helps your surgeon plan the right operation how is lobular cancer treated
well the principles of treatment are the same as any other breast cancer surgery to remove the cancer with a clear margin
of normal tissue followed by radiotherapy if needed and chemotherapy if needed followed by hormonal therapy
when it comes to surgery the outcome from a lumpectomy and a myectomy are the same providing all the cancer has been
removed but because lobular cancers tend to be large more women will end up having a myectomy compared to those with
ductal cancer what about chemotherapy so chemotherapy doesn't work very well for
most lobular Cancers and that's because they are so slow growing now if you have a very large cancer with involved lymph
nodes you might still be off at chemotherapy but most of you will be started on hormonal therapy instead and
you may be given targeted therapy like a cdk inhibitor and you can see this video to find out more there is hope that
molecular tests like oncotype and prosignia will be able to help your oncologists work out whether you really
need chemotherapy but at the moment there isn't a lot of information and that's because most trials don't
separate breast cancers by tumor type ductal and lobular endocrine therapy is the main
treatment that you have with an ER positive lobular breast cancer we want to lower the levels of Eid in your blood
to reduce the risk of lobular cancer coming back now there are trials looking at giving it to you before surgery to
try and shrink the cancer to help you avoid ostectomy there's not much evidence to
show whether one drug is better than another but there is some data hinting that LOL has a greater effect than
tamoxifen targeted therapy as I said earlier you may be given one of the cdk Inhibitors palicy which is what I'm on
aacy or ribosy together with a hormone blocker and this is to further reduce the risk of recurrence if you have a
large tumor now the pelops trial has just finished recruiting and that's looking at the benefit of giving palpac
cycp and endocrine therapy before surgery in patients with ductal and lobular cancer the results are expected
in 20131 does lobular cancer have a worse survival rate at the moment there is
isn't a lot of evidence to say one way or the other and your survival rate depends on lots of things and it means
How likely you are to still be alive 5 or 10 years after treatment now we work it out using a computer algorithm on
websites such as NHS predict and adant online and it takes into account your tumor size and grade are your lymph
nodes involved is your cancer ER or herty positive or negative how old you are however it doesn't ask whether your
cancer was ductal or lobular which is really annoying but that's because the vast majority of Trials over the years
have looked at how successful breast cancer treatment is by size and grade and receptors they didn't look at the
difference between ductal and lobular Cancers and that's why there isn't a lot of information to help the few studies
that there are have shown that lobular cancers have a better outcome in the first five years compared to ductal
cancers with fewer recurrences but as you get older and you get Beyond 10 years from your treatment it's the
lobular cancers that are more likely to come back why don't you have an MRI as followup
after lobular breast cancer this is so hard to explain and I used to struggle to get my patients to understand it and
then when I got lobular cancer I became a confused patient we do breast scans for the first 5 years after surgery for
two reasons one is to look for a recurrence in the breast assuming you had a lumpectomy because if you've had a
myectomy then there's no tissue left to scan the other is to look for a breast cancer in your Healthy breast
having breast cancer once means you are more likely to have it again compared to a healthy woman but you need to remember
things like chemotherapy and tamoxifen electrol reduce the risk of that happening there is also no guarantee
that if you had a lobular cancer a new cancer in your breast would be lobular as well it's just as easily to be a
ductal cancer which is seen on a mamogram so we start with a mamogram as they are useful in picking up changes
and if your cancer wasn't seen on a mamogram in the beginning your team may consider doing MRIs as well at the
moment there's no National policy for lobular followup but if you are worried you've got dense breasts your cancer was
missed talk to your team and ask them about regular MRI followup now what happens when lobular
cancer comes back at stage four disease now this might be scary to hear but it's really important to know because it can
come back 10 or even 20 years in the future you need to know what to look out for and yet again lobula can be sneaky
although it does go to the common sites such as your liver and Bones it can also spread to your abdominal cavity and the
cells invading the Linings of your gastrointestinal and gynecological organs can be affected such as your
stomach your ovaries your bow and your bladder and because the cells grow in sheets they can wrap around the organs
like a loose knot that slowly tightens and this means that you may have different symptoms of metastatic disease
such as indigestion and heart bur constipation or difficulty having a Wei if you do have an unusual symptom and
you've had it for more than three or four weeks and you can't explain it make sure you see your family doctor now they
might not remember that lobular cancer can spread to different sites so you might need to remind
them a lobular metastases hard to detect you guessed it lobular cancer is the gift that keeps on giving not only is
the primary cancer hard to spot but the metastases are as well and again that's because they're growing sheets and not a
lump now in 200 22 a survey at a big breast cancer conference in the states asked 271 women with lobular Mets how
they were diagnosed 48% said it was unexpected or an incidental finding during another medical procedure or scan
a third said at least one type of Imaging such as ultrasound or AC C failed to pick up one of their
metastatic sites we desperately need more research to help identify metastatic disease and liquid biopsies
might be just around the corner so what does the future look like for LOB cancer well there are several really exciting
areas of research at the moment and the first is immunotherapy lobular breast cancers
appeared to be immunologically hot meaning that your immune system is more likely to recognize a lobular cancer we
know there are also more active immune cells compared to ductal cancers and the gelato trial was the first immunotherapy
study for patients with lobular cancer it looked at using a drug called Tech Centric which is a pdl1 inhibitor
together with a chemotherapy drug called caroplast for patients with metastatic disease now
sadly it was stopped early because it didn't show a benefit and the side effects weren't great but other trials
will follow we also know that lobular cancers can have different genetic mutations
compared to ductal cancers for example scientists have discovered that 60% of lobular cancers
have a mutation in the pik3ca gene which is what I have and we think this causes endocrine resistance meaning that drugs
like tamoxifen stop working the solar 1 phase 3 trial tested a pi3k inhibitor called alpelisib in patients with
metastatic lobular disease and it showed it increased the length of time that patients had staple disease
for we also know that lobular cancers have a mutation in the cdh1 Gene and it's this mutation that stops the cells
producing eerin the Rolo trial is testing a drug called choton now this targets A protein that lobular cancer
cells rely on instead of eerin and we're hoping this will give us more information about how to treat lobular
cancer in the future if you found this video useful hit the Subscribe button so you don't miss my next one I'm Dr lizza
Raiden and thanks for watching I'll see you next time
Heads up!
This summary and transcript were automatically generated using AI with the Free YouTube Transcript Summary Tool by LunaNotes.
Generate a summary for freeRelated Summaries

Understanding Lysosomes and Their Role in Lysosomal Storage Disorders
Explore the intricate functioning of lysosomes and the impact of lysosomal storage disorders on human health.

The Rise of Lobster: From Poor Man's Protein to Gourmet Delicacy
This video explores the fascinating history of lobsters, tracing their transformation from a cheap food source to a luxury item. It delves into the factors contributing to their high prices, including supply challenges and market demand.

Embracing Body Positivity: A Journey of Self-Love and Acceptance
Discover the journey to body positivity and self-acceptance from cancer survivor Roshni's inspiring story.

Revolutionizing Recovery: The Power of Magnetic Field Therapy
Discover how magnetic field therapy aids recovery and enhances healing processes for serious injuries and conditions.

Understanding the Characteristics of Life: What Makes Us Alive?
Explore the essential characteristics defining life and biological growth! Stay curious with us at Amoeba Sisters.
Most Viewed Summaries

Mastering Inpainting with Stable Diffusion: Fix Mistakes and Enhance Your Images
Learn to fix mistakes and enhance images with Stable Diffusion's inpainting features effectively.

A Comprehensive Guide to Using Stable Diffusion Forge UI
Explore the Stable Diffusion Forge UI, customizable settings, models, and more to enhance your image generation experience.

How to Use ChatGPT to Summarize YouTube Videos Efficiently
Learn how to summarize YouTube videos with ChatGPT in just a few simple steps.

Ultimate Guide to Installing Forge UI and Flowing with Flux Models
Learn how to install Forge UI and explore various Flux models efficiently in this detailed guide.

How to Install and Configure Forge: A New Stable Diffusion Web UI
Learn to install and configure the new Forge web UI for Stable Diffusion, with tips on models and settings.